Quartile criteria | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P-value |
---|---|---|---|---|---|
 | ≤10 | 11 to 14 | 15 to 19 | ≥20 | for trend* |
VF/pulseless VT | Â | Â | Â | Â | Â |
Neurologically favorable outcome, % (n/N) | 23.4 (43/184) | 17.9 (47/263) | 10.8 (30/277) | 7.2 (12/167) | Â |
Unadjusted OR | Reference | 0.71 | 0.4 | 0.25 | < 0.001 |
(95% CI) | Â | (0.45 to 1.14) | (0.24 to 0.66) | (0.13 to 0.50) | Â |
Adjusted OR | Reference | 0.65 | 0.37 | 0.22 | < 0.001 |
(95% CI) | Â | (0.40 to 1.06) | (0.21 to 0.66) | (0.10 to 0.50) | Â |
PEA/Asystole | Â | Â | Â | Â | Â |
Neurologically favorable outcome, % (n/N) | 2.1 (18/877) | 1.7 (21/1,202) | 1.2 (14/1,148) | 0.6 (7/1,170) | Â |
Unadjusted OR | Reference | 0.85 | 0.59 | 0.29 | < 0.001 |
(95% CI) | Â | (0.45 to 1.60) | (0.29 to 1.19) | (0.12 to 0.69) | Â |
Adjusted OR | Reference | 0.82 | 0.57 | 0.27 | < 0.001 |
(95% CI) | Â | (0.41 to 1.61) | (0.26 to 1.26) | (0.09 to 0.81) | Â |